Lu Wen
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 19
- Molecular Biology top 1%
- Single-cell and spatial transcriptomics 35
- Epigenetics and DNA Methylation 26
- Renal and related cancers 14
- RNA modifications and cancer 13
- CRISPR and Genetic Engineering 10
- Biophysics top 1%
- Immunology top 5%
- Oncology top 5%
-
- Gastric Cancer Management and Outcomes 11
-
- Prenatal Screening and Diagnostics 9
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Lu Wen
184 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 1.9k
- Molecular Biology 5.8k
- Biophysics 245
- Immunology 751
- Oncology 855
Countries citing papers authored by Lu Wen
This map shows the geographic impact of Lu Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wen more than expected).
Fields of papers citing papers by Lu Wen
This network shows the impact of papers produced by Lu Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wen. The network helps show where Lu Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lu Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 34 | |
| 9 | 2023 | 60 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 38 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 14 | |
| 15 | 2020 | 36 | |
| 16 | 2019 | 41 | |
| 17 | 2019 | 23 | |
| 18 | 2018 | 133 | |
| 19 | Treatment of Radiation Enteritis by Changyun Mixture:A Clinical Observation of 42 Cases | 2007 | 1 |
| 20 | The experimental study of CPSC on anti-aging | 2001 | 1 |
About Lu Wen
Lu Wen is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 193 papers that have together received 8.1k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (35 papers), Epigenetics and DNA Methylation (26 papers), Cancer Genomics and Diagnostics (19 papers), Renal and related cancers (14 papers), RNA modifications and cancer (13 papers), Gastric Cancer Management and Outcomes (11 papers), CRISPR and Genetic Engineering (10 papers) and Prenatal Screening and Diagnostics (9 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (5.8k citations) and Biophysics (245 citations). Lu Wen has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Fuchou Tang, Xinglong Wu, Hongshan Guo, Ping Zhu, Jie Qiao, Xianlong Li, Liying Yan, Boqiang Hu, Ying Lian and Xiaoying Fan. Their work appears in journals such as Cell Research, Journal of Clinical Oncology, Genome biology, Clinical Radiology and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.